Maturitas

Editorial Board
pp. CO2-CO2(1)

Contents
pp. IV-IV(1)

P53 expression in spontaneous and estradiol-induced endometrial hyperplasia during menopause
pp. 175-180(6)
Authors: Maia H.; Maltez A.; Athayde C.; Coelho G.; Coutinho E.M.

Plasma and urinary sex hormones are differently related to lipids in healthy postmenopausal women
pp. 181-187(7)
Authors: Ossewaarde M.E.; Bots M.L.; van der Schouw Y.T.; Thijssen J.H.H.; Tineke Westerveld H.; de Jong F.H.; Grobbee D.E.

Adverse effects of a SERM (Levormeloxifene) - Safety parameters and bone mineral density 12 months after treatment withdrawal
pp. 189-199(11)
Authors: Warming L.; Christoffersen C.; Riis B.J.; Stakkestad J.A.; Delmas P.D.; Christiansen C.

Compliance with hormone replacement therapy in Thai women
pp. 201-205(5)
Authors: Manonai J.; Theppisai U.; Suchartwatnachai C.; Jetsawangsri T.; Chittacharoen A.

A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women
pp. 207-214(8)
Authors: Haines C.J.; Yim S.F.; Chung T.K.H.; Lam C.W.K.; Lau E.W.C.; Ng M.H.L.; Chin R.; Lee D.T.S.

Quantitative ultrasound of the calcaneus in arabian women: relation to anthropometric and lifestyle factors
pp. 215-223(9)
Authors: Saadi H.F.; Reed R.L.; Carter A.O.; Dunn E.V.; Qazaq H.S.; Al-Suhaili A.R.

Symptom experience in Australian men and women in midlife
pp. 225-236(12)
Authors: Calvaresi E.; Bryan J.

Performance and acceptability of intrauterine release of levonorgestrel with a miniature delivery system for hormonal substitution therapy, contraception and treatment in peri and postmenopausal women
pp. 237-245(9)
Authors: Wildemeersch D.; Schacht E.; Wildemeersch P.

Abstracts
pp. 247-250(4)

Announcements
pp. 251-251(1)